Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Oct 10, 2023

BUY
$57.77 - $65.93 $115 - $131
2 Added 0.61%
329 $19,000
Q2 2023

Jul 11, 2023

BUY
$60.95 - $75.51 $19,930 - $24,691
327 New
327 $20,000
Q3 2022

Oct 19, 2022

BUY
$66.18 - $82.86 $16,545 - $20,715
250 New
250 $16,000
Q1 2022

Apr 25, 2022

SELL
$66.02 - $79.71 $9,242 - $11,159
-140 Closed
0 $0
Q4 2021

Jan 10, 2022

BUY
$63.34 - $74.11 $8,867 - $10,375
140 New
140 $10,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.